Cargando…
Paper-Based Detection Device for Alzheimer’s Disease—Detecting β-amyloid Peptides (1–42) in Human Plasma
The diagnosis of Alzheimer’s disease (AD) is frequently missed or delayed in clinical practice. To remedy this situation, we developed a screening, paper-based (P-ELISA) platform to detect β-amyloid peptide 1–42 (Aβ42) and provide rapid results using a small volume, easily accessible plasma sample i...
Autores principales: | Sung, Wei-Hsuan, Hung, Jung-Tung, Lu, Yu-Jen, Cheng, Chao-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277973/ https://www.ncbi.nlm.nih.gov/pubmed/32365918 http://dx.doi.org/10.3390/diagnostics10050272 |
Ejemplares similares
-
Graphene based electrochemical immunosensor for the ultra-sensitive label free detection of Alzheimer's beta amyloid peptides Aβ(1–42)
por: Abbasi, Hina. Y., et al.
Publicado: (2021) -
Influence of Hyperglycemic Conditions on Self-Association
of the Alzheimer’s Amyloid β (Aβ(1–42)) Peptide
por: Menon, Sneha, et al.
Publicado: (2017) -
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2021) -
A Multi-Chamber Paper-Based Platform for the Detection of Amyloid β Oligomers 42 via Copper-Enhanced Gold Immunoblotting
por: Phan, Le-Minh-Tu, et al.
Publicado: (2021) -
Detection of Amyloid-β(1–42) Aggregation With a Nanostructured Electrochemical Sandwich Immunoassay Biosensor
por: Wang, Bing-Yu, et al.
Publicado: (2022)